Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines in UAE
183 medicines available
About Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines
This page lists all Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor medicines available in UAE pharmacies.
Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.
Complete List of Antineoplastic agent, Phosphatidylinositol 3-kinase (PI3K) inhibitor Medicines
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with acute myeloid leukemia (AML) with a FLT3 mutation and for the treatment of aggressive systemic mastocytosis (ASM)
Adult d...
Class: | Combination of a Rho kinase inhibitor (Netarsudil) and a prostaglandin analog (Latanoprost)
Use: | Indicated for the reduction of intraocular pressure in patients with open-angle glaucoma o...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with early-stage HER2-positive breast cancer, following adjuvant trastuzumab-based therapy; also indicated for metastatic HER2-p...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in adult and pediatric patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase, accelerated ph...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase, accelerated phase, or blast crisis...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of chronic myeloid leukemia (CML) in adults and pediatric patients with Philadelphia chromosome-positive (Ph+) CML in chronic phase or accelerated...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with newly diagnosed chronic phase Philadelphia chromosome-positive chronic myeloid leukemia (CML) and for patients with CML who...
Class: | Tyrosine kinase inhibitor (TKI)
Use: | Treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly for patients with T790M mutation after progression on prior EGFR TKI...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly in patients with T790M mutation who have progressed on prior EGFR-targeted...
Class:| Cyclin-dependent kinase (CDK) 4/6 inhibitor
Use:| Treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy
Adult dos...
Class: | Cyclin-dependent kinase (CDK) 4/6 inhibitor
Use: | Palbociclib is used in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of hormone receptor-po...
Class: | Cyclin-dependent kinase (CDK) 4/6 inhibitor
Use: | Palbociclib (IBRANCE) is used in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of hormone re...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of advanced renal cell carcinoma (RCC) and soft tissue sarcoma (STS)
Adult dose: | 800 mg orally once daily, taken without food; may be reduced ...
Class: | Bruton's tyrosine kinase (BTK) inhibitor
Use: | Treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have received at least one prior therapy
Adult dose:...
Class: | Bruton tyrosine kinase (BTK) inhibitor
Use: | Treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have received at least one prior therapy
Adult dose: |...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adult patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are resistan...
Class: | RET kinase inhibitor
Use: | Treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), RET-mutant medullary thyroid cancer (MTC), and RET fusion-pos...
Class: | Multikinase inhibitor
Use: | Regorafenib is used for the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST) after disease progression on or intolerance to ima...
Class: | Multikinase inhibitor
Use: | Regorafenib is used for the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST) that cannot be surgically removed and have progresse...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of moderate to severe alopecia areata in adults and pediatric patients aged 12 years and older
Adult dose: | 50 mg orally once daily
Pediat...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients who have had an inadequate response to or are intolerant of hydroxyur...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients resistant to or intolerant of hydroxyurea, and graft-versus-host dise...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of intermediate or high-risk myelofibrosis, polycythemia vera in patients with an inadequate response to hydroxyurea, and graft-versus-host dis...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of mild to moderate atopic dermatitis in adults and pediatric patients aged 12 years and older
Adult dose: | Apply a thin layer to the affect...
Class: | Janus kinase (JAK) inhibitor
Use: | Treatment of mild to moderate atopic dermatitis in adults and pediatric patients aged 12 years and older
Adult dose: | Apply a thin layer of Ruxolitini...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adults with non-small cell lung cancer (NSCLC) that is RET fusion-positive, and for adults and pediatric patients 12 years and older with advan...
Class: | Tyrosine Kinase Inhibitor
Use: | Treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), RET-mutant medullary thyroid cancer (MTC), and other RET-altered...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), advanced or metastatic medullary thyroid cancer (MTC), and advan...
Class: | Tyrosine kinase inhibitor
Use: | Treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), advanced or metastatic medullary thyroid cancer (MTC), and advan...